Activation of Drosophila hemocyte motility by the ecdysone hormone

Christopher J Sampson1, Unum Amin, Juan-Pablo Couso

  • 1JMS Building, University of Sussex, Brighton BN1 9QG, East Sussex, UK.

Biology Open
|November 29, 2013
PubMed

Insights

The hormone ecdysone activates Drosophila hemocyte motility, specifically plasmatocytes, during metamorphosis. This process requires the ecdysone receptor and cytoskeletal changes for cell movement.

Area of Science:

  • Invertebrate immunology
  • Developmental biology
  • Cellular signaling

Background:

  • Drosophila hemocytes are crucial for innate immunity, with plasmatocytes acting like macrophages.
  • Plasmatocytes are responsible for clearing pathogens and apoptotic cells during metamorphosis.
  • The activation mechanism of sessile hemocytes remains unclear, though ecdysone is a suspected signaling molecule.

Purpose of the Study:

  • To investigate the role of the hormone ecdysone in activating Drosophila hemocyte motility.
  • To determine the molecular requirements for ecdysone-induced hemocyte activation.

Main Methods:

  • Ex vivo culture of larval Drosophila hemocytes with 20-hydroxyecdysone.
  • Observation of hemocyte motility and cytoskeletal changes.
  • Analysis of ecdysone receptor complex involvement.

Main Results:

  • Ecdysone treatment induced motile behavior in larval hemocytes.
  • Ecdysone-induced cell motility requires the ecdysone receptor complex.
  • Motile hemocytes exhibited asymmetrical redistribution of actin and tubulin.

Conclusions:

  • Ecdysone acts as a key signaling molecule that activates hemocyte motility at metamorphosis.
  • The ecdysone receptor pathway mediates the transition of hemocytes from a quiescent to a migratory state.
  • Cytoskeletal rearrangements are essential for ecdysone-driven hemocyte migration.